Zealand Pharma
730
DKK
+0.41 %
ZEAL
NASDAQ Copenhagen
Biotechnology & Pharmaceuticals
Health Care
18 following
+0.41%
-13.04%
-17.14%
+11.71%
+95.61%
+121.08%
+425.94%
+260.67%
+818.24%
www.zealandpharma.com
Zealand Pharma is a biotechnology company. Particular focus is found in the development of drugs for the treatment of diabetes and various intestinal diseases. The company has a varied product portfolio with separate brands that are sold on a global level. The largest business is in the Nordic market. Zealand Pharma was founded in 1997 and is headquartered in Söborg, Denmark.
Revenue
342.79M
EBIT %
-166.94 %
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
NASDAQ Copenhagen
ZEAL
Daily low / high price
720.5 / 747.5
DKK
Market cap
51.85B DKK
Turnover
119.15M DKK
Volume
162K
Latest videos
Financial calendar
Annual report
20.02.2025
Interim report
08.05.2025
Interim report
14.08.2025
Interim report
06.11.2025
Major OwnersSource: Millistream Market Data AB
| Owner | Capital | Votes |
|---|---|---|
| Van Herk Investments | 16.8 % | 16.8 % |
| Credit Suisse Group AG | 6.2 % | 6.2 % |
ShowingAll content types
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Zealand Pharma Announces Financial Results for the First Nine Months of 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools